Related Experiment Video
Updated: Nov 8, 2025
12:02
Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
14.3K
Evolutionary algorithm-based generation of optimum peptide sequences with dengue virus inhibitory activity.
Stephen J Barigye1, José M García de la Vega1, Yunierkis Perez-Castillo2
1Departamento de Química Física Aplicada, Facultad de Ciencias, Universidad Autónoma de Madrid, 28049, Madrid, Spain.
Future Medicinal Chemistry
|April 23, 2021
Summary
A new computational tool, AutoPepGEN, designs peptides to inhibit dengue virus (DENV). This framework accelerates the discovery of potential DENV therapeutics by reducing experimental design complexity.
Area of Science:
- Computational biology
- Bioinformatics
- Drug discovery
Background:
- No effective therapeutics currently exist for dengue virus (DENV) infection.
- Developing novel DENV inhibitors is a critical unmet medical need.
Purpose of the Study:
- To develop a computational framework for designing peptides with potential dengue virus inhibitory activity.
- To utilize a genetic algorithm-based approach for optimizing peptide sequences.
Main Methods:
- Implemented AutoPepGEN, a Python-based tool employing a DENV support vector machine classifier.
- Applied AutoPepGEN to design short peptides (3-7 amino acids).
- Validated selected peptides using molecular docking and binding energy calculations.
Main Results:
- Ten potential DENV-inhibitory peptides were designed and selected by AutoPepGEN.
- Favorable binding energies were observed between the designed peptides and the DENV protease.
- The computational approach demonstrated efficiency in peptide sequence design.
Conclusions:
- AutoPepGEN offers an *in silico* alternative to traditional experimental methods for peptide library design.
- This tool can help overcome the combinatorial explosion issue in experimental drug discovery.
- The developed framework shows promise for accelerating the identification of DENV therapeutics.
